Practices That Reduce the Latina Survival Disparity After Breast Cancer
Overview
Affiliations
Objectives: Latina breast cancer patients are 20 percent more likely to die within 5 years after diagnosis compared with white women, even though they have a lower incidence of breast cancer, lower general mortality rates, and some better health behaviors. Existing data only examine disparities in the utilization of breast cancer care; this research expands the study question to which utilization factors drive the shorter survival in Latina women compared with white women.
Methods: This longitudinal linked Surveillance Epidemiology and End Results (SEER)-Medicare cohort study examined early stage breast cancer patients diagnosed between 1992 and 2000 and followed for 5-11 years after diagnosis (N=44,999). Modifiable utilization factors included consistent visits to primary care providers and to specialists after diagnosis, consistent post-diagnosis mammograms, and receipt of initial care consistent with current standards of care.
Results: Of the four utilization factors potentially driving this disparity, a lack of consistent post-diagnosis mammograms was the strongest driver of the Latina breast cancer survival disparity. Consistent mammograms attenuated the hazard of death from 23% [hazard ratio, HR, (95% confidence interval, 95%CI)=1.23 (1.1,1.4)] to a nonsignificant 12% [HR (95%CI)=1.12 (0.7,1.3)] and reduced the excess hazard of death in Latina women by 55%. Effect modification identified that visits to primary care providers have a greater protective impact on the survival of Latina compared to white women [HR (95%CI)=0.9 (0.9,0.9)].
Conclusions: We provide evidence that undetected new or recurrent breast cancers due to less consistent post-diagnosis mammograms contribute substantially to the long-observed Latina survival disadvantage. Interventions involving primary care providers may be especially beneficial to this population.
Mubarak F, Kowkabany G, Popp R, Bansal S, Ahmed S, Sharan S Cancers (Basel). 2024; 16(8).
PMID: 38672591 PMC: 11049226. DOI: 10.3390/cancers16081509.
Herbach E, Nash S, Lizarraga I, Carnahan R, Wang K, Ogilvie A Cancer Epidemiol Biomarkers Prev. 2023; 32(10):1312-1322.
PMID: 37436422 PMC: 10592343. DOI: 10.1158/1055-9965.EPI-23-0218.
Prieto D, Soto-Ferrari M, Tija R, Pena L, Burke L, Miller L Health Syst (Basingstoke). 2019; 8(2):75-98.
PMID: 31275571 PMC: 6598506. DOI: 10.1080/20476965.2018.1440925.
Smith-Gagen J, Loux T, Drake C, Perez-Stable E J Racial Ethn Health Disparities. 2016; 3(3):496-507.
PMID: 27294748 DOI: 10.1007/s40615-015-0167-y.